SUNPHARMA.NS · Sun Pharmaceutical Industries Limited
India · RS rating 52 · As of 2026-10-14
| Price | 1,746.40 INR |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 52 / 42 / 36 / 71 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 36 / 38 / 51 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | +7.1% |
| Sales growth Q/Q | +4.3% |
| Distance from 52-week high | +12.7% |
| Market cap (USD) | $44.4B |